GlassScriptPhysician profile
Shalin Shah
NPI 1124098249
$15,614.67
in general payments reported to CMS, 2019-2025
43 companies · $3,471 in 2025
The $3,471 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,151 · 2020: $2,692 · 2021: $1,236 · 2022: $2,487 · 2023: $1,175 · 2024: $1,403 · 2025: $3,471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,314 · Travel and Lodging: $735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,313.95 |
| Travel and Lodging | $734.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $3,045.92 | 2020-2024 | Qdot Micro Catheter, Carto 3, Octaray Mapping Catheter |
| Abbott Laboratories | $2,779.03 | 2019-2025 | Perclose Prostyle, Aveir, Ensite |
| Medtronic, INC. | $2,551.79 | 2021-2025 | Affera Mapping System, Micra, Cobalt Dr Mri Surescan |
| Boston Scientific Corporation | $2,305.89 | 2019-2025 | General - Therapies, Resonate El Icd Vr |
| Acutus Medical, INC. | $1,213.82 | 2021-2023 | |
| Medical Device Business Services, INC. | $888.35 | 2019 | |
| Novartis Pharmaceuticals Corporation | $307.36 | 2024-2025 | |
| Kestra Medical Technology Services, INC. | $225.23 | 2022-2024 | Assure Wcd |
| Cvrx, INC. | $191.11 | 2024-2025 | Barostim Neo System |
| Medtronic Vascular, INC. | $187.17 | 2019-2020 | |
| Edwards Lifesciences Corporation | $178.17 | 2025 | Sapien 3 Ultra Resilia |
| E.R. Squibb & Sons, L.L.C. | $156.82 | 2023-2025 | Eliquis, Camzyos |
| Impulse Dynamics (USA) INC. | $152.73 | 2024 | Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $146.38 | 2022-2025 | Lifevest |
| Gilead Sciences, INC. | $131.60 | 2024-2025 | Trodelvy |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galvanize Therapeutics, INC | $127.46 | 2025 | Aliya System |
| Amgen INC. | $112.36 | 2022-2025 | Repatha, Repatha |
| Pfizer INC. | $92.58 | 2025 | |
| Atricure, INC. | $78.37 | 2023-2025 | Atriclip Laa Exclusion System |
| Mirati Therapeutics, INC. | $64.88 | 2023-2024 | Krazati |
| Biotronik INC. | $63.09 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $58.68 | 2022-2023 | Verquvo |
| Myriad Genetic Laboratories, INC. | $47.88 | 2024 | Myrisk |
| Genentech USA, INC. | $42.67 | 2022-2025 | Polivy |
| Novo Nordisk INC | $40.58 | 2025 | Wegovy |
| Csl Behring | $35.85 | 2023-2025 | Idelvion, Afstyla |
| Inari Medical, INC. | $35.00 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $33.33 | 2024 | Fruzaqla |
| Tersera Therapeutics LLC | $30.35 | 2025 | Zoladex |
| Delcath Systems | $29.53 | 2025 | Hepzato Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.79 | 2023 | Jardiance |
| Shockwave Medical, INC | $24.26 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $24.21 | 2025 | Evkeeza |
| Legend Biotech USA INC. | $22.98 | 2024 | |
| Sanofi-Aventis U.S. LLC | $22.58 | 2023 | |
| Apellis Pharmaceuticals, INC. | $21.66 | 2023 | Empaveli |
| Philips North America LLC | $18.66 | 2025 | Lm Undivided |
| Curonix LLC | $18.40 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Cordis US Corp. | $18.40 | 2025 | Mynx Control Venous |
| Nuwellis, INC. | $16.89 | 2019 | |
| Elutia, INC. | $16.10 | 2024 | Ecm Patch,Pouch |
| Syndax Pharmaceuticals, INC. | $16.04 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $13.72 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shalin Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.